Australia markets open in 3 hours 52 minutes

BioSyent Inc. (RX.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
10.50+0.49 (+4.90%)
At close: 03:58PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 121.64M
Enterprise value 99.12M
Trailing P/E 17.95
Forward P/E 19.08
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.85
Price/book (mrq)3.52
Enterprise value/revenue 3.02
Enterprise value/EBITDA 10.05

Trading information

Stock price history

Beta (5Y monthly) 0.95
52-week change 342.47%
S&P500 52-week change 326.24%
52-week high 310.75
52-week low 37.03
50-day moving average 38.93
200-day moving average 38.54

Share statistics

Avg vol (3-month) 38.4k
Avg vol (10-day) 38.52k
Shares outstanding 511.58M
Implied shares outstanding 612.07M
Float 89.02M
% held by insiders 138.45%
% held by institutions 11.37%
Shares short (14 June 2024) 4300
Short ratio (14 June 2024) 40.05
Short % of float (14 June 2024) 4N/A
Short % of shares outstanding (14 June 2024) 40.00%
Shares short (prior month 15 May 2024) 4273

Dividends & splits

Forward annual dividend rate 40.18
Forward annual dividend yield 41.71%
Trailing annual dividend rate 30.17
Trailing annual dividend yield 31.65%
5-year average dividend yield 4N/A
Payout ratio 428.21%
Dividend date 315 June 2024
Ex-dividend date 431 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 21.48%
Operating margin (ttm)27.02%

Management effectiveness

Return on assets (ttm)12.94%
Return on equity (ttm)20.75%

Income statement

Revenue (ttm)32.84M
Revenue per share (ttm)2.77
Quarterly revenue growth (yoy)19.30%
Gross profit (ttm)N/A
EBITDA 8.41M
Net income avi to common (ttm)7.05M
Diluted EPS (ttm)0.58
Quarterly earnings growth (yoy)50.50%

Balance sheet

Total cash (mrq)23.69M
Total cash per share (mrq)2.05
Total debt (mrq)1.18M
Total debt/equity (mrq)3.40%
Current ratio (mrq)7.72
Book value per share (mrq)2.97

Cash flow statement

Operating cash flow (ttm)7.11M
Levered free cash flow (ttm)6.52M